475 related articles for article (PubMed ID: 28640209)
21. Design, synthesis and biological evaluation of quinoline-indole derivatives as anti-tubulin agents targeting the colchicine binding site.
Li W; Shuai W; Sun H; Xu F; Bi Y; Xu J; Ma C; Yao H; Zhu Z; Xu S
Eur J Med Chem; 2019 Feb; 163():428-442. PubMed ID: 30530194
[TBL] [Abstract][Full Text] [Related]
22. Identification of Essential 2D and 3D Chemical Features for Discovery of the Novel Tubulin Polymerization Inhibitors.
Azimi F; Ghasemi JB; Saghaei L; Hassanzadeh F; Mahdavi M; Sadeghi-Aliabadi H; Scotti MT; Scotti L
Curr Top Med Chem; 2019; 19(13):1092-1120. PubMed ID: 31109275
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological evaluation of quinoline analogues of flavones as potential anticancer agents and tubulin polymerization inhibitors.
Shobeiri N; Rashedi M; Mosaffa F; Zarghi A; Ghandadi M; Ghasemi A; Ghodsi R
Eur J Med Chem; 2016 May; 114():14-23. PubMed ID: 26974371
[TBL] [Abstract][Full Text] [Related]
24. Structural insight into SSE15206 in complex with tubulin provides a rational design for pyrazolinethioamides as tubulin polymerization inhibitors.
Ma L; Lei J; Chen H; Huang R; Su T; Feng J; Sun Q
Future Med Chem; 2022 Jun; 14(11):785-794. PubMed ID: 35506429
[No Abstract] [Full Text] [Related]
25. Synthesis, anticancer activity and molecular docking studies on a series of heterocyclic trans-cyanocombretastatin analogues as antitubulin agents.
Penthala NR; Zong H; Ketkar A; Madadi NR; Janganati V; Eoff RL; Guzman ML; Crooks PA
Eur J Med Chem; 2015 Mar; 92():212-20. PubMed ID: 25557492
[TBL] [Abstract][Full Text] [Related]
26. 5-Amino-2-aroylquinolines as highly potent tubulin polymerization inhibitors.
Nien CY; Chen YC; Kuo CC; Hsieh HP; Chang CY; Wu JS; Wu SY; Liou JP; Chang JY
J Med Chem; 2010 Mar; 53(5):2309-13. PubMed ID: 20148562
[TBL] [Abstract][Full Text] [Related]
27. Identification of novel αβ-tubulin modulators with antiproliferative activity directed to cancer therapy using ligand and structure-based virtual screening.
Federico LB; Silva GM; de Fraga Dias A; Figueiró F; Battastini AMO; Dos Santos CBR; Costa LT; Rosa JMC; de Paula da Silva CHT
Int J Biol Macromol; 2020 Dec; 165(Pt B):3040-3050. PubMed ID: 33736292
[TBL] [Abstract][Full Text] [Related]
28. Recent advances in research of colchicine binding site inhibitors and their interaction modes with tubulin.
Sun K; Sun Z; Zhao F; Shan G; Meng Q
Future Med Chem; 2021 May; 13(9):839-858. PubMed ID: 33821673
[TBL] [Abstract][Full Text] [Related]
29. 2-Anilino-3-Aroylquinolines as Potent Tubulin Polymerization Inhibitors.
Srikanth PS; Nayak VL; Suresh Babu K; Kumar GB; Ravikumar A; Kamal A
ChemMedChem; 2016 Sep; 11(18):2050-62. PubMed ID: 27465681
[TBL] [Abstract][Full Text] [Related]
30. Discovery of novel 2-phenyl-imidazo[1,2-a]pyridine analogues targeting tubulin polymerization as antiproliferative agents.
An W; Wang W; Yu T; Zhang Y; Miao Z; Meng T; Shen J
Eur J Med Chem; 2016 Apr; 112():367-372. PubMed ID: 26927488
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and fungicidal activity of quinolin-6-yloxyacetamides, a novel class of tubulin polymerization inhibitors.
Lamberth C; Kessabi FM; Beaudegnies R; Quaranta L; Trah S; Berthon G; Cederbaum F; Knauf-Beiter G; Grasso V; Bieri S; Corran A; Thacker U
Bioorg Med Chem; 2014 Aug; 22(15):3922-30. PubMed ID: 25002231
[TBL] [Abstract][Full Text] [Related]
32. Thiazolidinone Constraint Combretastatin Analogs as Novel Antitubulin Agents: Design, Synthesis, Biological Evaluation and Docking Studies.
Sharma S; Gupta MK; Saxena AK; Bedi PM
Anticancer Agents Med Chem; 2017; 17(2):230-240. PubMed ID: 27141882
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological evaluation of (1-aryl-1H-pyrazol-4-yl) (3,4,5-trimethoxyphenyl)methanone derivatives as tubulin inhibitors.
Zhai M; Wang L; Liu S; Wang L; Yan P; Wang J; Zhang J; Guo H; Guan Q; Bao K; Wu Y; Zhang W
Eur J Med Chem; 2018 Aug; 156():137-147. PubMed ID: 30006160
[TBL] [Abstract][Full Text] [Related]
34. Hydropathic analysis and biological evaluation of stilbene derivatives as colchicine site microtubule inhibitors with anti-leukemic activity.
Tripathi A; Durrant D; Lee RM; Baruchello R; Romagnoli R; Simoni D; Kellogg GE
J Enzyme Inhib Med Chem; 2009 Dec; 24(6):1237-44. PubMed ID: 19912057
[TBL] [Abstract][Full Text] [Related]
35. The compound millepachine and its derivatives inhibit tubulin polymerization by irreversibly binding to the colchicine-binding site in β-tubulin.
Yang J; Yan W; Yu Y; Wang Y; Yang T; Xue L; Yuan X; Long C; Liu Z; Chen X; Hu M; Zheng L; Qiu Q; Pei H; Li D; Wang F; Bai P; Wen J; Ye H; Chen L
J Biol Chem; 2018 Jun; 293(24):9461-9472. PubMed ID: 29691282
[TBL] [Abstract][Full Text] [Related]
36. Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin.
Bhattacharyya B; Panda D; Gupta S; Banerjee M
Med Res Rev; 2008 Jan; 28(1):155-83. PubMed ID: 17464966
[TBL] [Abstract][Full Text] [Related]
37. Identification of pyrrolopyrimidine derivative PP-13 as a novel microtubule-destabilizing agent with promising anticancer properties.
Gilson P; Josa-Prado F; Beauvineau C; Naud-Martin D; Vanwonterghem L; Mahuteau-Betzer F; Moreno A; Falson P; Lafanechère L; Frachet V; Coll JL; Fernando Díaz J; Hurbin A; Busser B
Sci Rep; 2017 Aug; 7(1):10209. PubMed ID: 28860487
[TBL] [Abstract][Full Text] [Related]
38. G-1 Inhibits Breast Cancer Cell Growth via Targeting Colchicine-Binding Site of Tubulin to Interfere with Microtubule Assembly.
Lv X; He C; Huang C; Hua G; Wang Z; Remmenga SW; Rodabough KJ; Karpf AR; Dong J; Davis JS; Wang C
Mol Cancer Ther; 2017 Jun; 16(6):1080-1091. PubMed ID: 28258163
[TBL] [Abstract][Full Text] [Related]
39. An update on the recent advances and discovery of novel tubulin colchicine binding inhibitors.
Weng H; Li J; Zhu H; Carver Wong KF; Zhu Z; Xu J
Future Med Chem; 2023 Jan; 15(1):73-95. PubMed ID: 36756851
[TBL] [Abstract][Full Text] [Related]
40. Optimization of Benzamide Derivatives as Potent and Orally Active Tubulin Inhibitors Targeting the Colchicine Binding Site.
Lin S; Du T; Zhang J; Wu D; Tian H; Zhang K; Jiang L; Lu D; Sheng L; Li Y; Ji M; Chen X; Xu H
J Med Chem; 2022 Dec; 65(24):16372-16391. PubMed ID: 36511661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]